Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
August 4
 · 
Be the first to react
MyMyelomaTeam

It's completely natural to want to hear from others who've been through CAR T-cell therapy — and many MyMyelomaTeam members have shared their journeys. While individual experiences vary, here's a general picture of what people tend to go through:

Before treatment
- Your T cells are collected through a process called Show Full Answer

It's completely natural to want to hear from others who've been through CAR T-cell therapy — and many MyMyelomaTeam members have shared their journeys. While individual experiences vary, here's a general picture of what people tend to go through:

Before treatment:
- Your T cells are collected through a process called apheresis (a machine separates them from your blood)
- The cells are engineered in a lab, which takes a few weeks
- Just before the infusion, you'll receive a short course of chemotherapy to prepare your body

During and after:
- The modified T cells are given back through an IV infusion
- Most people stay in hospital for several weeks afterward for monitoring
- Even after discharge, staying close to the treatment center for a month or more is common Side effects to be aware of:

The most commonly reported side effect is cytokine release syndrome (CRS), which can cause fever, chills, breathing difficulties, and confusion. Most people experience a mild version, though it can occasionally be more serious. There are medications available to treat it if needed.

Some people also experience neurological symptoms like confusion or difficulty speaking, so the medical team will monitor closely for this.

Other common side effects include:
- Fatigue
- Nausea
- Headache
- Infections
- Loss of appetite On the encouraging side, a recent study found that 1 in 3 people with relapsed or hard-to-treat myeloma remained in remission for at least five years after a single infusion of Carvykti — without needing ongoing treatment. That's a really meaningful result.

Going into this with open conversations with your care team about what to expect is the best preparation. You're in good hands! 💪

August 4

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Ohatchee, AL

A MyMyelomaTeam Member asked a question 💭
Wrentham, MA

A MyMyelomaTeam Member asked a question 💭
Long Island, NY